Importance of Radiopharmaceuticals in the Bone Scan Market
Government initiatives in healthcare infrastructure are driving the Bone Scan Market. Investments in nuclear medicine facilities and advanced imaging centers are enabling wider access.
With a projected CAGR of 5.7%, the market will grow from USD 825 million in 2023 to USD 1.35 billion by 2032. Countries prioritizing healthcare modernization, particularly in Asia-Pacific and Latin America, are seeing higher adoption rates.
Public sector funding, along with private collaborations, is enhancing accessibility, making the Bone Scan Market a key segment in healthcare advancement.
1 View